Kiora Pharmaceuticals (KPRX) Return on Sales (2016 - 2024)
Kiora Pharmaceuticals' Return on Sales history spans 10 years, with the latest figure at 0.22% for Q4 2024.
- For Q4 2024, Return on Sales changed N/A year-over-year to 0.22%; the TTM value through Dec 2024 reached 0.22%, changed N/A, while the annual FY2024 figure was 0.22%, N/A changed from the prior year.
- Return on Sales reached 0.22% in Q4 2024 per KPRX's latest filing, down from 0.36% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 15023.71% in Q3 2023 to a low of 831.2% in Q1 2021.
- Average Return on Sales over 5 years is 3683.65%, with a median of 1214.61% recorded in 2021.
- Peak YoY movement for Return on Sales: soared 1107070bps in 2023, then crashed -1502336bps in 2024.
- A 5-year view of Return on Sales shows it stood at 97.32% in 2020, then surged by 3679bps to 3483.0% in 2021, then grew by 13bps to 3953.01% in 2022, then surged by 280bps to 15023.71% in 2023, then tumbled by -100bps to 0.22% in 2024.
- Per Business Quant, the three most recent readings for KPRX's Return on Sales are 0.22% (Q4 2024), 0.36% (Q3 2024), and 0.21% (Q2 2024).